HUE026461T2 - Pyrazole derivatives suitable as aldosterone synthase inhibitors - Google Patents
Pyrazole derivatives suitable as aldosterone synthase inhibitors Download PDFInfo
- Publication number
- HUE026461T2 HUE026461T2 HUE12727984A HUE12727984A HUE026461T2 HU E026461 T2 HUE026461 T2 HU E026461T2 HU E12727984 A HUE12727984 A HU E12727984A HU E12727984 A HUE12727984 A HU E12727984A HU E026461 T2 HUE026461 T2 HU E026461T2
- Authority
- HU
- Hungary
- Prior art keywords
- compound
- mmol
- pharmaceutically acceptable
- benzonitrile
- acceptable salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161496657P | 2011-06-14 | 2011-06-14 | |
| US201161506349P | 2011-07-11 | 2011-07-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE026461T2 true HUE026461T2 (en) | 2016-05-30 |
Family
ID=46317515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE12727984A HUE026461T2 (en) | 2011-06-14 | 2012-06-07 | Pyrazole derivatives suitable as aldosterone synthase inhibitors |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US8778984B2 (sl) |
| EP (1) | EP2721009B1 (sl) |
| JP (1) | JP5890012B2 (sl) |
| KR (1) | KR101555119B1 (sl) |
| CN (1) | CN103596930B (sl) |
| AR (1) | AR086665A1 (sl) |
| AU (1) | AU2012271023A1 (sl) |
| BR (1) | BR112013031873A2 (sl) |
| CA (1) | CA2836804C (sl) |
| CL (1) | CL2013003536A1 (sl) |
| CO (1) | CO6821955A2 (sl) |
| CR (1) | CR20130601A (sl) |
| CY (1) | CY1116687T1 (sl) |
| DK (1) | DK2721009T3 (sl) |
| DO (1) | DOP2013000284A (sl) |
| EA (1) | EA201391655A1 (sl) |
| EC (1) | ECSP13013080A (sl) |
| ES (1) | ES2548210T3 (sl) |
| GT (1) | GT201300307A (sl) |
| HK (1) | HK1193103A1 (sl) |
| HR (1) | HRP20150939T1 (sl) |
| HU (1) | HUE026461T2 (sl) |
| IL (1) | IL229485A0 (sl) |
| ME (1) | ME02223B (sl) |
| MX (1) | MX336042B (sl) |
| PE (1) | PE20140606A1 (sl) |
| PL (1) | PL2721009T3 (sl) |
| PT (1) | PT2721009E (sl) |
| RS (1) | RS54269B1 (sl) |
| SG (1) | SG194822A1 (sl) |
| SI (1) | SI2721009T1 (sl) |
| TW (1) | TWI518073B (sl) |
| WO (1) | WO2012173849A1 (sl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110845482B (zh) * | 2014-07-04 | 2024-01-19 | 日本烟草产业株式会社 | 制备吲哚化合物的方法 |
| CN108586221B (zh) * | 2018-06-26 | 2021-03-02 | 常州制药厂有限公司 | 用于制备替卡格雷的中间体及其制备方法 |
| CN112409432B (zh) * | 2020-11-16 | 2023-07-07 | 陕西理工大学 | 一种依西美坦的合成方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57165369A (en) * | 1981-04-06 | 1982-10-12 | Teijin Ltd | Pyrazole derivative and its preparation |
| US4617307A (en) * | 1984-06-20 | 1986-10-14 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors |
| US5057521A (en) * | 1988-10-26 | 1991-10-15 | Ciba-Geigy Corporation | Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism |
| GT200600381A (es) * | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| WO2007111175A1 (ja) | 2006-03-17 | 2007-10-04 | Ngk Insulators, Ltd. | 目封止ハニカム構造体の製造方法 |
| JP5575913B2 (ja) | 2009-11-30 | 2014-08-20 | ノバルティス アーゲー | アルドステロン合成酵素阻害剤としてのイミダゾール誘導体 |
| SI2523731T1 (sl) | 2010-01-14 | 2019-02-28 | Novartis Ag | Uporaba sredstva, ki modificira adrenalni hormon |
-
2012
- 2012-06-04 AR ARP120101967A patent/AR086665A1/es unknown
- 2012-06-04 TW TW101120004A patent/TWI518073B/zh not_active IP Right Cessation
- 2012-06-07 HU HUE12727984A patent/HUE026461T2/en unknown
- 2012-06-07 RS RS20150619A patent/RS54269B1/en unknown
- 2012-06-07 SG SG2013082367A patent/SG194822A1/en unknown
- 2012-06-07 CN CN201280028717.6A patent/CN103596930B/zh not_active Expired - Fee Related
- 2012-06-07 PL PL12727984T patent/PL2721009T3/pl unknown
- 2012-06-07 CA CA2836804A patent/CA2836804C/en not_active Expired - Fee Related
- 2012-06-07 WO PCT/US2012/041212 patent/WO2012173849A1/en active Application Filing
- 2012-06-07 EA EA201391655A patent/EA201391655A1/ru unknown
- 2012-06-07 DK DK12727984.2T patent/DK2721009T3/en active
- 2012-06-07 AU AU2012271023A patent/AU2012271023A1/en not_active Abandoned
- 2012-06-07 BR BR112013031873A patent/BR112013031873A2/pt not_active IP Right Cessation
- 2012-06-07 ES ES12727984.2T patent/ES2548210T3/es active Active
- 2012-06-07 MX MX2013014790A patent/MX336042B/es unknown
- 2012-06-07 KR KR1020137032885A patent/KR101555119B1/ko not_active IP Right Cessation
- 2012-06-07 ME MEP-2015-131A patent/ME02223B/me unknown
- 2012-06-07 SI SI201230283T patent/SI2721009T1/sl unknown
- 2012-06-07 EP EP12727984.2A patent/EP2721009B1/en active Active
- 2012-06-07 PE PE2013002810A patent/PE20140606A1/es not_active Application Discontinuation
- 2012-06-07 JP JP2014515877A patent/JP5890012B2/ja not_active Expired - Fee Related
- 2012-06-07 PT PT127279842T patent/PT2721009E/pt unknown
- 2012-06-07 US US13/490,530 patent/US8778984B2/en not_active Expired - Fee Related
-
2013
- 2013-11-18 IL IL229485A patent/IL229485A0/en unknown
- 2013-11-18 CR CR20130601A patent/CR20130601A/es unknown
- 2013-12-02 DO DO2013000284A patent/DOP2013000284A/es unknown
- 2013-12-10 CL CL2013003536A patent/CL2013003536A1/es unknown
- 2013-12-11 GT GT201300307A patent/GT201300307A/es unknown
- 2013-12-11 CO CO13290174A patent/CO6821955A2/es active IP Right Grant
- 2013-12-13 EC ECSP13013080 patent/ECSP13013080A/es unknown
-
2014
- 2014-07-02 HK HK14106679.9A patent/HK1193103A1/xx not_active IP Right Cessation
-
2015
- 2015-09-07 HR HRP20150939TT patent/HRP20150939T1/hr unknown
- 2015-09-11 CY CY20151100789T patent/CY1116687T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2089367B1 (en) | Pyrazoline compounds as mineralocorticoid receptor antagonists | |
| EP2598513A1 (en) | Compounds and methods for treating neoplasia | |
| UA71610C2 (uk) | Біциклічні гетероцикли та фармацевтична композиція на їх основі | |
| MX2015001880A (es) | 2,3-benzodiacepinas. | |
| JP6268276B2 (ja) | ＰＥＲＫ阻害剤としての新規なＮ（２，３−ジヒドロ−１Ｈ−ピロロ［２，３−ｂ］ピリジン−５−イル）−４−キナゾリンアミン誘導体およびＮ−（２，３−ジヒドロ−１Ｈ−インドール−５−イル）−４−キナゾリンアミン誘導体 | |
| CN108864079A (zh) | 一种三嗪化合物及其药学上可接受的盐 | |
| DK2721009T3 (en) | Pyrazole derivatives MAY BE USED AS ALDOSTERONSYNTASEHÆMMERE | |
| JP6884973B2 (ja) | 疼痛に対して活性を有するオキサジアザスピロ化合物 | |
| CN102020640A (zh) | 四氢吲哚酮和四氢吲唑酮衍生物、其制备方法及其在医药上的应用 | |
| CA3068146A1 (en) | Heterochromatin gene repression inhibitors | |
| JP2018531263A6 (ja) | 疼痛に対して活性を有するオキサジアザスピロ化合物 | |
| CA2999940A1 (en) | Substituted morpholine derivatives having activity against pain | |
| NZ617642B2 (en) | Pyrazole derivatives useful as aldosterone synthase inhibitors | |
| WO2006104008A1 (ja) | ウレア誘導体、それを含有する医薬組成物およびそれらの医薬用途 | |
| CN110669049B (zh) | 新型雄激素受体抑制剂及其合成方法和应用 | |
| KR20120070353A (ko) | 올메사탄 메독소밀의 유연물질의 제조방법 | |
| JP2018526365A (ja) | １−（４−（２−（（１−（３，４−ジフルオロフェニル）−１ｈ−ピラゾール−３−イル）メトキシ）エチル）ピペラジン−１−イル）エタノン塩 | |
| KR20230069915A (ko) | 신규 화합물 | |
| WO2014182688A1 (en) | Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto | |
| WO2024129026A1 (en) | The use of ezetimibe and its synthesis intermediates and isopazopanib structured molecules as anticancer agents | |
| TW202400608A (zh) | 雜芳族巨環醚化合物之固體形式、醫藥組合物及製備 | |
| JP2018531267A6 (ja) | 疼痛に対して活性を有するオキサ−アザスピロ化合物 |